Granahan Investment Management, LLC Ironwood Pharmaceuticals Inc Transaction History

Granahan Investment Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$8.27 - $12.73 $3.27 Million - $5.04 Million	-395,574 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$7.8 - $16.13 $75,270 - $155,654	-9,650 Reduced 2.38%	395,574 $4.1 Million
Q3 2018 Nov 13, 2018	SELL	$14.31 - $17.65 $1.66 Million - $2.04 Million	-115,664 Reduced 22.21%	405,224 $7.48 Million
Q2 2018 Aug 15, 2018	BUY	$11.83 - $16.2 $766,442 - $1.05 Million	64,788 Added 14.2%	520,888 $9.96 Million
Q1 2018 May 14, 2018	BUY	$11.13 - $13.63 $722,337 - $884,587	64,900 Added 16.59%	456,100 $7.04 Million
Q4 2017 Feb 12, 2018	SELL	$12.16 - $14.58 $544,768 - $653,184	-44,800 Reduced 10.28%	391,200 $5.86 Million
Q3 2017 Nov 14, 2017	BUY	$12.07 - $14.87 $5.26 Million - $6.48 Million	436,000	436,000 $6.88 Million

237

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $682M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Granahan Investment Management, LLC with notifications on news.